The Patient Signal

In this episode, we explore the dynamic landscape of the medical device industry as it heads into 2026, with mergers and acquisitions taking center stage. We discuss Boston Scientific's significant acquisition of Penumbra and the challenges posed by expiring Affordable Care Act subsidies and tariffs. We also delve into the ongoing negotiations for the Medical Device User Fee Amendments and the competitive field of surgical robotics. Next, we highlight Nona Biosciences' co-founding of the Innovative Alliance for Translational Medicine in Immunological Diseases, aiming to advance research and clinical trials in immunological diseases. We then turn to Stellaromics' expansion of its Pyxa™ 3D spatial transcriptomics program, now installed at Emory University, to enhance research into RNA regulation in neurodegenerative diseases. Meanwhile, a collaboration in Taiwan has developed an exosome-based drug delivery platform for Parkinson's disease, showing promise in preclinical studies. In other news, the U.S. Department of Health and Human Services has issued new guidance to reduce prescription drug prices through Direct-to-Consumer programs, aiming to make medications more affordable. We also discuss the biotech industry's challenge with AI-driven medical breakthroughs, emphasizing the need for accessible AI infrastructure to ensure diverse innovation. Finally, BioMed X partners with Barbados and the EU to launch a project improving AI-based early diabetic kidney disease modeling, focusing on the Barbadian population's health challenges. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.medtechdive.com/news/medtech-trends-outlook-2026/810902/ https://www.biospace.com/press-releases/nona-biosciences-co-founds-innovative-alliance-for-translational-medicine-in-immunological-diseases-advancing-a-new-iit-driven-ecosystem https://www.biospace.com/press-releases/stellaromics-expands-pyxa-3d-spatial-transcriptomics-beta-program-with-installation-at-emory-university-school-of-medicine https://www.biospace.com/press-releases/cmuh-ever-supreme-team-develops-world-first-brain-targeting-exosome-delivering-curcumin-across-the-blood-brain-barrier-for-parkinsons-disease https://www.pharmexec.com/view/daily-disconnect-between-pharma-medtech https://pharmaphorum.com/digital/ais-promise-biotechs-peril-how-unequal-access-computing-power-threatens-medical https://www.genengnews.com/topics/translational-medicine/barbados-government-and-biomed-x-partner-to-improve-ai-based-early-diabetic-kidney-disease-modeling

In this episode, we delve into Neuralink's groundbreaking clinical trials with 21 "Neuralnauts" using the Telepathy device, allowing quadriplegics to control devices through thought. We also cover BD and Waters' $17.5 billion merger, set to double Waters' market reach. Phacilitate's Advanced Therapies Week 2026 highlights cell and gene therapy advancements amid regulatory challenges. Minaris enhances its Viral Clearance lab in Philadelphia, boosting efficiency for cell and gene therapies. Akido Labs launches an AI-powered street medicine program in the Bay Area to aid the homeless. iXCells Biotechnologies and Rosebud Biosciences partner to advance organoid-based models for rare disease research. Lastly, Boehringer Ingelheim's apecotrep shows promise in treating a rare kidney disease, marking a significant step in their kidney disorder pipeline. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://teslanorth.com/2026/01/28/from-paralysis-to-neuroscience-how-21-people-are-using-neuralink-in-2026/ https://www.medtechdive.com/news/bd-water-merger-completion-date/810678/ https://www.biospace.com/drug-development/advanced-therapies-week-2026-solving-for-science-and-weathering-global-complexity https://www.biospace.com/press-releases/minaris-announces-viral-clearance-laboratory-upgrade-at-philadelphia-campus https://www.fiercehealthcare.com/providers/akido-labs-partners-launch-ai-powered-street-medicine-program-bay-area https://www.genengnews.com/topics/translational-medicine/ix-cells-and-rosebud-biosciences-partner-on-organoid-based-rare-disease-models https://pharmaphorum.com/news/boehringer-drug-scores-rare-kidney-disease-fsgs

In this episode, we explore the latest developments in healthcare and biotechnology. Medtronic expands its collaboration with Mindray to integrate patient monitoring technologies into ambulatory surgery centers, supporting the shift of surgical procedures from hospitals to same-day care settings. Mair Therapeutics partners with Radboud University to advance TMEM175 agonists for Parkinson's disease, leveraging human neuron models to assess lysosomal function. Chulalongkorn University in Thailand enhances its AI-powered tool, Deep GI, to detect gastrointestinal lesions, aiming for broader adoption in endoscopy centers. The FDA approves a groundbreaking study on cell reset to potentially slow or reverse aging, backed by Life Biosciences. Lastly, Rosanna Zhang from ACROBiosystems discusses the use of organoids in neuroscience research, offering promising insights into neurological disease modeling and treatment development. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.medtechdive.com/news/medtronic-mindray-asc-collaboration/810568/ https://www.biospace.com/press-releases/mair-therapeutics-announces-scientific-collaboration-with-radboud-university-to-advance-tmem175-agonists-for-parkinsons-disease https://www.mobihealthnews.com/news/asia/thailand-world-chulalongkorn-university-developing-global-cadx-gi-cancers https://endpoints.news/exclusive-fda-greenlights-gene-therapy-study-to-rewind-the-age-of-cells/ https://www.news-medical.net/news/20260127/Scientists-offer-new-insight-into-how-common-parasite-T-gondii-causes-disease.aspx

In this episode, we explore Medtronic's recent CE mark approval for its Affera Sphere-360 pulsed field ablation catheter, designed to treat paroxysmal atrial fibrillation. This innovative device offers a competitive edge by ablating target tissue without rotation, contributing to a significant surge in Medtronic's PFA sales and supporting their strategy to enhance profit margins. Next, we delve into the advancements in Parkinson's disease treatment, highlighting investigational therapies targeting underlying mechanisms. Companies like Ventyx Therapeutics, AC Immune, Gain Therapeutics, Denali Therapeutics, and Biogen are pioneering precision medicine approaches to develop more effective treatments. Moving on, we discuss the challenges and breakthroughs in overcoming the Blood-Brain Barrier (BBB) for neurological disease treatment. Innovations in antibody technology, such as Receptor-Mediated Transcytosis and bispecific antibodies, are paving the way for effective drug delivery across the BBB, promising a transformation in brain disease treatment. Meanwhile, the clinical diagnostics sector is set for significant advancements by 2026, driven by technological innovations and data integration. The rise of AI, machine learning, and wearable devices is expected to enhance diagnostic accuracy, speed, and accessibility, empowering patients and healthcare providers alike. On that note, nearly 30,000 COPD patients in England may soon benefit from Dupixent, a biologic treatment by Sanofi and Regeneron, following NHS recommendation. This targeted therapy aims to reduce flare-ups and improve lung function, potentially saving the NHS millions annually. Finally, researchers from New England Biolabs and Yale University have developed a synthetic bacteriophage engineering system to combat antibiotic resistance. This innovative approach simplifies phage engineering, offering a promising solution against multi-drug resistant bacteria like Pseudomonas aeruginosa. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.medtechdive.com/news/medtronic-wins-ce-mark-for-single-shot-pulsed-field-ablation-catheter/810448/ https://www.biospace.com/drug-development/5-investigational-therapies-that-could-change-the-parkinsons-landscape https://www.biospace.com/press-releases/overcoming-the-wall-how-far-has-bbb-crossing-antibody-technology-truly-advanced-commentary-by-unexakorea https://www.fiercehealthcare.com/sponsored/whats-next-clinical-diagnostics-2026 https://pharmaphorum.com/news/copd-patients-will-get-access-dupixent-nhs https://www.genengnews.com/topics/infectious-diseases/antibiotic-resistance-combatted-by-fully-synthetic-bacteriophage-assembly

In this episode, we cover several significant developments in the healthcare and pharmaceutical industries. Integra LifeSciences has recalled certain wound and burn treatment devices due to packaging failures that could lead to infections, with 14 serious injuries reported. Curant Rare and Cencora have partnered to streamline the commercialization of rare disease therapies, aiming to overcome regulatory and access challenges. AION Labs is advancing drug discovery by integrating AI and quantum technologies, positioning itself at the forefront of innovation. IQVIA is enhancing clinical research with Agentic AI, improving trial efficiency and accuracy. NICE has approved digital health technologies for NHS use to support individuals with osteoarthritis and bulimia, aligning with digital transformation goals. Cellular Origins and Fresenius Kabi are collaborating to automate cell and gene therapy manufacturing, reducing costs and manual intervention. We also discuss the importance of intersectionality in healthcare workforces, the integration of AI in medicine, and the foundational elements of health disparities science. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.medtechdive.com/news/integra-recalls-wound-burn-devices-medihoney/810323/ https://www.biospace.com/press-releases/curant-rare-announces-collaboration-with-cencora-to-support-commercialization-of-rare-and-orphan-drug-products https://www.mobihealthnews.com/video/using-quantum-technology-drug-discovery https://www.appliedclinicaltrialsonline.com/view/the-key-to-clinical-trial-success-patient-tokenization https://pharmaphorum.com/news/digital-osteoarthritis-bulimia-tools-backed-nhs-use https://www.genengnews.com/topics/bioprocessing/milestone-reached-in-cell-and-gene-therapy-robotic-automation-and-manufacturing-collaboration/ https://www.thelancet.com/pdfs/journals/lanam/PIIS2667-193X(24)00300-4.pdf https://ai.nejm.org/doi/full/10.1056/AIe2300197 https://jamanetwork.com/journals/jama-health-forum/fullarticle/2812750

In this episode, we explore the latest developments in the healthcare and pharmaceutical industries. The European Commission has approved Otsuka's Dawnzera for preventing recurrent attacks in hereditary angioedema, a rare disease, marking a significant advancement in treatment options. Medtronic plans a substantial investment in Anteris Technologies, contingent on a successful public stock offering, to support the development of the DurAVR aortic heart valve. Meanwhile, life sciences companies are increasingly rejecting proposals against diversity, equity, and inclusion initiatives, recognizing their strategic importance. Anamika Shrimali shares her experience with the HPV vaccine, highlighting the need for better vaccine accessibility and awareness. Mayo Clinic's Ugur Sener and Taylor Galloway introduce an innovative approach to brain cancer care through the Neuro-Oncology Anywhere clinical trial portfolio. Taconic Biosciences enhances its research capabilities by acquiring TransCure bioServices, strengthening its platform for humanized mouse translational research. In other news, GE HealthCare and Epic Systems navigate challenges in AI investment and antitrust allegations, while health insurance executives face congressional scrutiny. Finally, the evolution of global trial strategies is reshaping clinical research, emphasizing collaboration and technological integration to enhance patient care and medical advancements. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://pharmaphorum.com/news/eu-approves-otsukas-long-acting-hae-drug-dawnzera https://www.medtechdive.com/news/medtronic-buy-up-to-90m-stake-heart-valve-anteris/810110/ https://www.appliedclinicaltrialsonline.com/view/business-case-dei-pharmaceutical-innovation-organizational-commitment-inclusive-clinical-trials https://www.statnews.com/2026/01/21/what-psa-screening-gets-wrong-prostate-cancer/ https://www.mobihealthnews.com/news/mayo-clinic-rethinking-brain-cancer-care-digital-transformation https://www.biospace.com/press-releases/taconic-biosciences-acquires-transcure-bioservices-building-a-comprehensive-global-platform-for-humanized-mouse-translational-research https://www.modernhealthcare.com/events/mh-roi-profitability-playbook-parminder-bhatia-ge-healthcare/ https://www.appliedclinicaltrialsonline.com/view/life-sciences-dei-startup-timelines-regulators-align-ai-governance

In this episode, we delve into Congress's landmark health care agreement targeting pharmacy benefit management reforms, telehealth expansion, and increased science funding to enhance transparency, reduce costs, and improve access to care. Boston Scientific's $14.5 billion acquisition of Penumbra aims to bolster its vascular surgery market presence, while Zydus Lifesciences' acquisition of Agenus Inc.'s biologics facilities positions it in the CDMO sector. Owkin's CEO discusses leveraging AI for disease understanding, and the rising prevalence of Parkinson's disease highlights the need for gender-specific research. Agentic AI promises to transform drug development by 2026, and life sciences companies reaffirm their commitment to DEI initiatives. Finally, Massachusetts General Hospital's AI system shows promise in early cognitive decline detection. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.statnews.com/2026/01/19/diabetes-study-bariatric-surgery-better-than-glp-1s/ https://www.medtechdive.com/news/boston-scientific-penumbra-deal-takeaways/809988/ https://www.biospace.com/press-releases/zydus-lifesciences-limited-completes-the-acquisition-of-agenus-inc-s-biologics-manufacturing-facilities-launches-zylidac-bio-llc-in-the-u-s https://www.mobihealthnews.com/news/qa-owkin-ceo-building-ai-scientist-and-pharmas-short-term-thinking https://www.appliedclinicaltrialsonline.com/view/women-missing-voice-parkinsons-disease https://pharmaphorum.com/digital/agentic-ai-shift-rd-rp-will-deliver-first-predictive-drug-pipeline-2026 https://www.appliedclinicaltrialsonline.com/view/business-case-dei-pharmaceutical-innovation-organizational-commitment-inclusive-clinical-trials https://pharmaphorum.com/news/autonomous-ai-can-spot-cognitive-decline-medical-notes

In this episode, we delve into a groundbreaking study published in 2026 that challenges long-held beliefs about the genetic causes of vision impairment. The research reveals that many genes linked to inherited eye diseases rarely result in vision loss, prompting a reevaluation of genetic counseling and testing practices. Next, we explore the new guidelines released by the European Medicines Agency and the U.S. FDA for integrating artificial intelligence into drug development. These principles focus on ethical alignment, human-centric design, and maintaining patient safety while fostering innovation. We then shift to insights from JPM Week in San Francisco, where biotech leaders discussed the industry's shift from market risk to geopolitical challenges, emphasizing the need to adapt strategies in response to global events. Meanwhile, Eli Lilly and NVIDIA have announced a $1 billion partnership to establish an AI co-innovation lab, aiming to revolutionize drug development and clinical processes through advanced AI technologies. Finally, Fresenius Kabi and TQ Therapeutics have teamed up to enhance cell and gene therapy accessibility, integrating cutting-edge cell selection technology to streamline production and accelerate treatment availability for patients. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.managedhealthcareexecutive.com/view/5-key-takeaways-on-most-favored-nations-pricing-from-mjh-life-sciences-webinar https://pharmaphorum.com/news/ema-and-fda-agree-principles-ai-drug-development https://medcitynews.com/2026/01/how-does-geopolitics-affect-the-life-sciences-industry-3-executives-weigh-in/ https://www.mobihealthnews.com/news/jpm-nvidia-and-eli-lilly-announce-co-innovation-ai-lab https://www.biospace.com/press-releases/fresenius-kabi-tq-therapeutics-announce-cell-therapy-technology-agreement

In this episode, we explore key developments in the global life sciences and biotech sectors. Telangana is set to unveil its Next-Generation Life Sciences Policy 2026–2030 at the World Economic Forum, aiming to position itself as a top global life sciences hub. The U.S. biotech sector faces challenges from inconsistent funding and regulations, risking its global leadership. Lilly and NVIDIA announce a $1 billion AI-focused co-innovation lab in South San Francisco, while Illumina launches the Billion Cell Atlas to enhance AI-driven drug discovery. Hippocratic AI acquires Grove AI to boost its life sciences capabilities. Changes to the UK's Voluntary Pricing and Access Scheme are underway following a UK-US trade deal. Lastly, Rosanna Zhang from ACROBiosystems discusses the use of organoids in neuroscience research, offering new insights into brain disorders. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.metroindia.net/news/articlenews/telangana-to-unveil-next-gen-life-sciences-policy-at-davos-34250 https://www.biospace.com/policy/opinion-trump-must-make-biotech-innovation-a-national-priority https://www.drugdiscoverytrends.com/lilly-and-nvidia-unveil-1b-co-innovation-lab-in-sf/ https://www.genengnews.com/topics/drug-discovery/ai-and-drug-discovery-get-a-boost-from-illuminas-billion-cell-atlas-release https://pharmaphorum.com/news/hippocratic-ai-builds-life-sciences-grove-ai-buy https://pharmaphorum.com/market-access/changes-uks-vpag-non-submissions-should-be-key-metric-impact https://www.news-medical.net/news/20260114/Disease-responsive-nanoparticles-enable-ghrelin-mRNA-therapy-in-osteoarthritis.aspx

In this episode, we explore a range of recent developments in healthcare and technology: 1. A study highlights the positive impact of Medicaid expansion on lung cancer survival rates, emphasizing the importance of healthcare accessibility. 2. Mavacamten shows promise in treating pediatric obstructive hypertrophic cardiomyopathy, offering a potential new therapeutic option for children. 3. The clinical trial landscape is evolving with platformization and AI, leading to more efficient and patient-centric trials. 4. Medtronic's MiniMed Go app, designed to enhance glycemic control, receives FDA clearance, marking a step forward in diabetes management. 5. CareDx and 10x Genomics launch ImmuneScape, a program aimed at understanding transplant rejection through advanced multiomics. 6. Ro partners with Amgen to improve access to GLP-1 medications, addressing barriers to obesity care. 7. ACA enrollment for 2026 is slower, impacted by premium increases, yet remains higher than expected. 8. Digital health funding surges in 2025, driven by AI investments, despite challenges in the sector. 9. Pharmacy closures affect healthcare delivery, especially in rural areas, highlighting the need for policy interventions. 10. Anthropic introduces Claude for Healthcare, an AI tool suite to reduce administrative burdens and enhance patient care. 11. Asimov and AGC Biologics collaborate on a new viral vector production approach, simplifying the process and reducing costs. 12. A study finds TikTok videos by physicians more reliable for breast cancer prevention, stressing the importance of sourcing medical information from professionals. 13. Nemours Children's Health launches the Advanced Care at Home program, reducing hospital stays and improving outcomes for children. 14. Researchers explore automated models to improve CT scan efficiency, reducing radiation exposure and enhancing diagnostic accuracy. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.managedhealthcareexecutive.com/view/patient-facing-ehr-tool-improves-lung-cancer-screening-identification https://www.drugtopics.com/view/impact-of-pharmacy-closures-reaches-far-beyond-medication-access https://www.appliedclinicaltrialsonline.com/view/trial-competition-slows-ai-gains-rethinking-patient-level-safety-decisions-real-ai-platforms-clinical-trials https://www.medtechdive.com/news/medtronic-clearance-insulin-pen-app-abbott/809479/ https://www.mobihealthnews.com/news/caredx-10x-genomics-partner-decode-transplant-rejection-cellular-resolution https://www.biospace.com/press-releases/ro-announces-research-collaboration-to-better-understand-and-improve-the-real-world-patient-experience-with-glp-1s https://www.healthcaredive.com/news/aca-enrollment-2026-cms-obamacare-snapshot/809445/ https://www.healthcaredive.com/news/digital-health-funding-2025-boosted-ai-rock-health/809449/ https://www.drugtopics.com/view/mavacamten-shows-improvements-for-pediatric-obstructive-hypertrophic-cardiomyopathy https://www.appliedclinicaltrialsonline.com/view/clinical-trials-2026-platformization-ai-fluency-value-chain https://pharmaphorum.com/news/jpm-anthropic-reveals-its-answer-chatgpt-health

In this episode, we explore key developments from the JPMorgan Healthcare Conference, where biotech companies made waves despite the lack of major announcements, highlighting the sector's ongoing growth potential. Chai Discovery's collaboration with Eli Lilly aims to enhance biologics discovery using AI, following a successful Series B funding round. VieCure secured $43 million to expand its AI-powered Halo Intelligence platform, emphasizing democratizing precision medicine. Applied Clinical Trials Online discusses the role of digital technologies in clinical trials, while NVIDIA's partnerships with Eli Lilly and Thermo Fisher aim to integrate AI into drug discovery and laboratory operations. NEJM AI examines cognitive biases in AI systems, stressing the need for fair and accurate applications. The New England Journal of Medicine highlights ethical considerations in medical AI, and JAMA Network Open evaluates AI's reliability in providing nutritional information. Finally, NVIDIA and Eli Lilly's $1 billion investment in an AI co-innovation lab promises to revolutionize drug discovery and manufacturing processes. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.statnews.com/2026/01/12/noubar-afeyan-letter-investors-jpm-2026/ https://www.biospace.com/press-releases/chai-discovery-announces-collaboration-with-eli-lilly-and-company-to-accelerate-biologics-discovery https://www.mobihealthnews.com/news/viecure-raises-43m-cancer-care-platform https://www.appliedclinicaltrialsonline.com/ https://pharmaphorum.com/news/nvidia-announces-lily-thermo-fisher-partnerships-jpm https://ai.nejm.org/doi/abs/10.1056/AIcs2400639 https://www.nejm.org/doi/full/10.1056/NEJMra2214183 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2813295 https://hitconsultant.net/2026/01/12/nvidia-and-eli-lilly-launch-ai-co-innovation-lab-to-reinvent-drug-discovery/

In this episode, we explore how data, AI, and capital are transforming the life sciences industry as 2026 begins. We start with Accenture and Salesforce's new AI-powered life sciences cloud, designed to streamline operations and improve decision-making. Next, we discuss Alexandra Beneville's appointment at Phreesia, enhancing their life sciences content strategy. We then highlight a company's expanded AI partnership to accelerate clinical development. Eytan Ellenberg delves into the complexities of drug causality, while Haisco Pharmaceutical's AirNexis spinout targets the Western market with a new respiratory treatment. We also cover a study favoring risk-based breast cancer screening over traditional methods. Finally, we examine the $4.9 billion funding surge in biotech as the J.P. Morgan Healthcare Conference approaches. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.fiercebiotech.com/medtech/accenture-joins-salesforce-build-out-ai-powered-cloud-service-life-sciences-companies https://www.mmm-online.com/home/channel/phreesia-appoints-alexandra-beneville-vp-of-life-sciences-content-strategy https://www.appliedclinicaltrialsonline.com/view/medidata-biorender-announce-new-ai-partnerships-expanding-capabilities-life-sciences https://www.appliedclinicaltrialsonline.com/view/conference-calls-for-unity-in-addressing-artificial-intelligence-regulation-in-life-sciences-research-and-development https://www.biocentury.com/article/658026/haisco-steps-onto-global-stage-with-blue-chip-newco-deal https://www.managedhealthcareexecutive.com/view/top-3-opportunities-artificial-intelligence-healthcare https://endpoints.news/private-and-public-biotechs-go-on-4-8b-funding-spree-ahead-of-jpm/

In this episode, we explore the FDA's new guidance exempting certain wellness features and clinical decision support tools from medical device oversight, fostering innovation in wearables and software. We also delve into the role of AI in pharmaceutical customer relations, highlighting the need for seamless integration to enhance sales and support. Eli Lilly's acquisition of Ventyx Biosciences marks a significant expansion in immunology, while the biopharma industry sees a strategic focus on metabolic medicines despite fewer partnerships. Color Health's collaboration with Evry Health aims to integrate cancer care into employer health plans, and PwC calls for a reinvention in biopharma to stay competitive. Adam Feuerstein reports on the biotech industry's maturation, and Sam Ash emphasizes careful AI implementation in healthcare. Tensive Srl's bioabsorbable breast implant shows promising trial results, and Boltz PBC launches to democratize AI in drug discovery. Parabilis Medicines secures funding for desmoid tumor treatments, and venture capital in healthcare increasingly focuses on AI integration. Finally, collaborations like Anthropic with Genmab and Hippocratic AI with Boston Consulting Group highlight AI's growing role in healthcare innovation, while AI's impact on oral surgery diagnostics is explored in the British Dental Journal. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.medtechdive.com/news/fda-exempts-wearable-ai-features-guidance/809099/ https://medcitynews.com/2026/01/pharmas-make-or-break-moment-how-ai-is-rewriting-the-rules-of-customer-engagement/ https://medcitynews.com/2026/01/eli-lilly-ventyx-biosciences-acquisition-nlrp3-inhibitor-inflammation-vtyx-lly/ https://medcitynews.com/2026/01/j-p-morgan-report-obesity-diabetes-dealmaking-set-a-new-record-in-2025/ https://medcitynews.com/2026/01/color-health-partners-with-evry-health-to-expand-access-to-virtual-cancer-care/ https://www.fiercebiotech.com/biotech/build-future-pharmas-must-embrace-ai-patient-experience-and-new-rd-frontiers-pwc https://www.statnews.com/2026/01/08/ocular-therapeutix-wet-amd-axpaxli/ https://www.beckershospitalreview.com/healthcare-information-technology/ai/why-some-cios-are-reining-in-ai/ https://www.bioworld.com/topics/85-bioworld-medtech https://www.genengnews.com/topics/artificial-intelligence/boltz-pbc-launches-with-28m-to-democratize-ai-platforms-for-drug-discovery/ https://pharmaphorum.com/news/parabilis-scores-305m-bumper-biofinancing-week https://hitconsultant.net/2026/01/09/the-flight-to-quality-why-2026-healthcare-vc-is-betting-on-ai-integration-over-innovation/ https://www.mobihealthnews.com/news/anthropic-genmab-partner-use-claude-rd-and-more-digital-health-news https://www.nature.com/articles/s41415-025-9509-2 ...

Welcome to today's episode, where we explore the latest in health and technology. OpenAI has launched ChatGPT Health, a new feature designed to integrate personal health information with AI, helping users manage their health more effectively. This innovation reflects a growing trend in healthcare towards using advanced technologies to enhance patient care. In other news, Surgerii Robotics, a Chinese surgical robot manufacturer, has raised $100 million to expand the global reach of its SHURUI single port endoscopic surgical robot. This advancement highlights the competitive landscape of robotic surgery, with Surgerii competing against major players like Intuitive Surgical. Shifting to public health, concerns have arisen over potential conflicts of interest as a panel developing new dietary guidelines has financial ties to the beef and dairy industries. This situation raises questions about the integrity and transparency of these influential recommendations. In the pharmaceutical sector, Eli Lilly is acquiring Ventyx Biosciences for $1.2 billion to bolster its focus on oral immune drugs targeting inflammatory conditions. This acquisition enhances Lilly's portfolio in obesity and metabolic treatments. Lastly, AI-driven drug discovery company Earendil has secured a $2 billion deal with Sanofi, emphasizing the growing role of AI in the pharmaceutical industry. This partnership aims to accelerate drug discovery, showcasing AI's potential to revolutionize the development of new therapies. Stay tuned for more insights and updates on the intersection of technology and health. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://medcitynews.com/2026/01/openai-chatgpt-healthcare-privacy-data/ https://www.medtechdive.com/news/Surgerii-Robotics-raises-100M-fund-global-expansion/809056/ https://www.statnews.com/2026/01/06/fda-pulls-back-oversight-ai-enabled-devices-wearables/?utm_campaign=rss https://www.biopharmadive.com/news/lilly-ventyx-acquire-deal-nlrp3-inflammasome/808988/ https://www.bioworld.com/articles/727792-ai-drug-discovery-brings-2b-sanofi-deal-to-1-year-old-earendil

In this episode, we delve into recent developments in politics, health care, and technology. Former President Donald Trump has called on Republicans to adopt a more flexible approach to abortion restrictions to secure a health care deal, emphasizing the need for compromise to achieve broader legislative goals. Meanwhile, Biobeat Technologies has raised $50 million to introduce its innovative cuffless blood pressure monitor to the U.S. market, despite skepticism from cardiovascular health bodies. Lastly, Insilico Medicine has partnered with Servier in a groundbreaking $888 million collaboration to leverage AI for drug discovery, highlighting the growing role of technology in the pharmaceutical industry. Join us as we explore these stories and their implications for the future. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.statnews.com/2026/01/06/fda-pulls-back-oversight-ai-enabled-devices-wearables/?utm_campaign=rss https://www.medtechdive.com/news/biobeat-raises-50m-cuffless-blood-pressure/808817/ https://www.bioworld.com/articles/727787-insilico-inks-888m-drug-discovery-partnership-with-servier

In this episode, we explore President Donald Trump's recent executive order establishing a unified national policy for AI development, aiming to override various state regulations. This move seeks to address concerns from health IT companies about inconsistent state laws, promoting a cohesive strategy across the healthcare sector. We also delve into the biotech sector, where Adam Feuerstein outlines 26 key stock-moving events for the first quarter of 2026, highlighting pivotal trial results and regulatory decisions that could reshape the industry. Additionally, we discuss the evolution of AI in healthcare, with Agentic AI transitioning from standalone models to "digital co-workers," potentially easing clinician burnout. Finally, we cover the American Medical Association's call for Congress to make permanent the Medicare telehealth flexibilities introduced during the Covid-19 pandemic, emphasizing the need for stable telehealth access for Medicare beneficiaries. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.healthcareitnews.com/news/health-it-companies-seek-clearer-more-consistent-rules-ai-development https://www.statnews.com/2026/01/05/neuralink-brain-computer-interface-medical-device-vs-transhumanism/ https://medcitynews.com/2026/01/healthcare-ai-agent/ https://medcitynews.com/2026/01/ama-to-congress-make-medicare-telehealth-services-permanent/

In this episode, we explore the transformative role of AI in the pharmaceutical industry, highlighting Insilico Medicine's Rentosertib, the first AI-discovered drug poised for Phase 3 clinical trials. With AI investments projected to reach $16.49 billion by 2034, industry leaders like Eli Lilly are at the forefront, collaborating with tech giants to revolutionize drug discovery. Despite AI's promise, experts caution about its limitations in human trials. We also delve into the challenges hospitals face with new medical technology, likening it to a prisoner's dilemma. While robotic systems promise improved care, the costs and rapid tech advancements pose strategic dilemmas for healthcare providers. Lastly, we discuss the DEA's extension of telemedicine prescribing flexibilities through 2026, a move applauded by telehealth advocates. This extension aims to ensure continued access to care while balancing human expertise with technology in healthcare practices. Join Stan Berteloot, a French journalist and AI expert, as he navigates these intersections of technology and culture. As Head of Strategy and CTO at Nytro Marketing, Stan brings insights from his AI-driven content creation initiatives and his podcast, Back in America. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://qz.com/pharma-ai-research-progress-lilly-insilico https://www.statnews.com/2026/01/02/hospitals-robots-training-prisoners-dilemma/ https://medcitynews.com/2026/01/extension-remote-prescribing-flexibilities/

In this episode, we delve into the recent appointment of a key adviser to Robert F. Kennedy Jr. on vaccine policy to the CDC, marking a significant shift in the agency's approach to children's health research. This move could signal a broadening of perspectives within the CDC, as the adviser, known for challenging mainstream vaccine consensus, steps into a new role focused on improving health outcomes for children. We also highlight three major public health issues to watch in 2026: the ongoing battle against infectious diseases, the growing focus on mental health integration into primary care, and the rising concern of climate change's impact on public health. These topics underscore the need for resilient health systems and collaborative efforts to ensure equitable access to care. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.statnews.com/2025/12/27/nih-neurological-disorders-stroke-institute-director-koroshetz-ousted/ https://www.statnews.com/2025/12/26/public-health-2026-issues-to-watch/?utm_campaign=rss

This episode moves from brand strategy to public health strategy, and shows how leadership choices ripple through both worlds. We start with Kenvue’s global agency shakeup, bringing WPP and Publicis into clearly defined lanes as the company looks to streamline execution and push growth across a $1.6B ad footprint. Then we zoom out to 2026’s vaccine reality: mandates, access, and the race to develop new vaccines, all colliding with politics, logistics, and trust. From there, we connect the dots to a year of medtech turbulence: lawsuits, ERP failures, M&A, leadership turnovers, layoffs, and regulatory pressure shaping how companies operate. Finally, we end with a concrete medical milestone: the first FDA-approved treatment for TA-TMA, a rare and severe complication after stem cell transplants, and what it signals about the future of targeted therapies. In this episode: • Why Kenvue’s partner model matters for speed, accountability, and scale • What vaccine policy fights reveal about trust and governance • The medtech stories that defined 2025’s risk landscape • A breakthrough FDA approval that could change outcomes for transplant patients Thanks for listening to this episode. We also discuss the challenges facing vaccine policy in 2026, including debates over mandates, distribution to underserved communities, and the development of new vaccines for emerging diseases. In the medtech industry, 2025 was marked by significant changes, such as Zimmer Biomet's lawsuit against Deloitte and Johnson & Johnson's major acquisitions. Leadership shifts and strategic refocusing were prevalent, with companies like Olympus and Medtronic adapting to evolving market demands. Finally, we highlight Omeros's groundbreaking FDA-approved treatment for a severe stem cell transplant complication, showcasing the potential of targeted therapies in addressing complex medical challenges. Join us as we navigate these dynamic stories and their implications for the future. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.mmm-online.com/news/kenvue-assigns-global-creative-duties-to-wpp-and-media-to-publicis/ https://www.statnews.com/2025/12/26/best-of-2025-health-science-biotech/ https://www.massdevice.com/the-10-most-read-medtech-news-stories-of-2025/ https://medcitynews.com/2025/12/fatal-complication-of-stem-cell-transplants-gets-its-first-fda-approved-therapy/

Welcome to the Legaltech News Podcast, where we delve into the dynamic intersection of law and technology. Stay informed with our expert analysis on the latest trends in legal tech, from AI integration in legal processes to tackling cybersecurity threats. Discover how legal departments can boost efficiency and cut costs, while law firms enhance client services with innovative tools. We also spotlight tech companies driving change in the legal sector. In today's episode, we explore Dr. Thomas Kelly's inspiring journey from medicine to legaltech innovation. After leaving his medical career, Kelly developed AI tools like Heidi, an AI medical scribe, to ease doctors' administrative burdens. His venture has attracted significant funding, highlighting AI's transformative potential in traditional fields. Join us as we provide the insights you need to navigate the rapidly evolving legal tech landscape and make informed decisions. Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://www.law.com/2025/12/24/health-care-and-life-science-stakeholders-value-ai-for-regulatory-monitoring/ https://www.cnbc.com/2025/12/24/he-left-medicine-to-build-an-ai-tool-now-its-worth-460-million.html